RA Capital Management’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.4M | Hold |
2,866,733
| – | – | 0.9% | 26 |
|
|
2025
Q1 | $52M | Buy |
2,866,733
+1,000,333
| +54% | +$18.1M | 0.87% | 23 |
|
|
2024
Q4 | $40.7M | Sell |
1,866,400
-466,600
| -20% | -$10.2M | 0.54% | 38 |
|
|
2024
Q3 | $63.9M | Hold |
2,333,000
| – | – | 0.74% | 31 |
|
|
2024
Q2 | $60.4M | Hold |
2,333,000
| – | – | 0.8% | 33 |
|
|
2024
Q1 | $70M | Buy |
+2,333,000
| New | +$70M | 0.89% | 30 |
|
|
2022
Q4 | – | Sell |
-224,255
| Closed | -$5.06M | – | 73 |
|
|
2022
Q3 | $5.06M | Buy |
+224,255
| New | +$5.06M | 0.11% | 69 |
|